Interrupting the adenoma carcinoma sequence: Screening for adenomas and cancer, now and in the future

Seminars in Gastrointestinal Disease

Volumn 11, Issue 4, 2000, Pages 219-228

  Schoen, R E ^a  

^a Division of Gastroenterology   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CANCER MORTALITY; CANCER SCREENING; COLON ADENOMA; COLON CARCINOGENESIS; COLON CARCINOMA; HUMAN; OCCULT BLOOD; REVIEW;

ADENOMA; CARCINOMA; COLONOSCOPY; COLORECTAL NEOPLASMS; HUMAN; OCCULT BLOOD; SIGMOIDOSCOPY;

EID: 0033790646     PISSN: 10495118     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (82)

1. Cancer statistics, 1999
2. The annual report to the nation on the status of cancer, 1973-1997, with a special section on colorectal cancer
3. Biologic characteristics of interval and screen-detected breast cancers
4. Breast Cancer Surveillance Consortium: A national mammography screening and outcomes database
5. Colorectal cancer mortality: Effectiveness of biennial screening for fecal occult blood
6. Randomised controlled trial of faecal-occult-blood screening for colorectal cancer
7. Randomised study of screening for colorectal cancer with faecal-occult-blood test
8. Fecal occult blood screening in the Minnesota study: Sensitivity of the screening test
9. A comparison of fecal occult-blood tests for colorectal-cancer screening
10. Accuracy of fecal occult blood screening for colorectal neoplasia. A prospective study using Hemoccult and HemoQuant tests
11. What can we conclude from the randomized controlled trials of fecal occult blood test screening?
12. Improving the cost-effectiveness of colorectal cancer screening
13. The findings and impact of nonrehydrated guaiac examination of the rectum (FINGER) study: A comparison of 2 methods of screening for colorectal cancer in asymptomatic average-risk patients
14. Cost-effectiveness model for colon cancer screening
15. Use of a pediatric colonoscope improves the success of total colonoscopy in selected adult patients
16. Screening sigmoidoscopy and colorectal cancer mortality
17. A case-control study of screening sigmoidoscopy and mortality from colorectal cancer
18. Prevention of colorectal cancer by once-only sigmoidoscopy
19. Uptake, yield of neoplasia, and adverse effects of flexible sigmoidoscopy screening
20. UK flexible sigmoidoscopy screening trial: Compliance, yield and adverse effects
21. Sigmoidoscopy use among primary care physicians
22. Primary care physicians' decisions to perform flexible sigmoidoscopy
23. Factors associated with the use of flexible sigmoidoscopy as a screening test for the detection of colorectal carcinoma by primary care physicians
24. Patient satisfaction with screening flexible sigmoidoscopy
25. Repeat screening flexible sigmoidoscopy in the prostate, lung, colorectal, and ovarian (PLCO) cancer screening trial
26. Barriers to office-based screening sigmoidoscopy: Does reimbursement cover costs?
27. Accuracy of polyp detection by gastroenterologists and nurse endoscopists during flexible sigmoidoscopy: A randomized trial
28. Is colonoscopy needed for the nonadvanced adenoma found on sigmoidoscopy? The Polyp Prevention Trial
29. Predicting advanced proximal colonic neoplasia with screening sigmoidoscopy
30. Importance of adenomas 5 mm or less in diameter that are detected by sigmoidoscopy
31. Neoplasia distal to the splenic flexure in patients with proximal colon cancer
32. Prospective determination of distal colon findings in average-risk patients with proximal colon cancer
33. The yield of a second screening flexible sigmoidoscopy in average-risk persons after one negative examination
34. Colorectal cancer screening: Is one-year surveillance sigmoidoscopy necessary?
35. Colorectal cancer screening: Clinical guidelines and rationale
36. Colorectal cancer prevention 2000: Screening recommendations of the American College of Gastroenterology
37. Prevention of colorectal cancer by colonoscopic polypectomy. The National Polyp Study Workgroup
38. Screening colonoscopy in asymptomatic average-risk persons with negative fecal occult blood tests
39. Screening for colon malignant with colonoscopy
40. A prospective study of the prevalence of colonic neoplasms in asymptomatic patients with an age-related risk
41. Population-based colonoscopy screening for colorectal cancer is feasible and safe: Preliminary results from the VA colonoscopy screening trial
42. Use of colonoscopy to screen asymptomatic adults for colorectal cancer
43. A national population-based study of incidence of colorectal cancer and age. Implications for screening in older Americans
44. A description of age, sex, and site distributions of colon carcinoma in three geographic areas
45. Is colonoscopy needed for the nonadvanced adenoma found on sigmoidoscopy?
46. Adenoma characteristics at first colonoscopy as predictors of adenoma recurrence and characteristics at follow-up. The Polyp Prevention Study Group
47. Adenoma size and number are predictive of adenoma recurrence: Implications for surveillance colonoscopy
48. Randomized comparison of surveillance intervals after colonoscopic removal of newly diagnosed adenomatous polyps. The National Polyp Study Workgroup
49. Initial management and follow-up surveillance of patients with colorectal adenomas
50. Lack of effect of a low-fat, high-fiber diet on the recurrence of colorectal adenomas. Polyp Prevention Trial Study Group
51. Colonoscopic miss rates of adenomas determined by back-to-back colonoscopies
52. Prospective blinded trial of the colonoscopic miss-rate of large colorectal polyps
53. Flat and depressed colonic neoplasms: A prospective study of 1000 colonoscopies in the UK
54. Five-year incidence of adenomas after negative colonoscopy in asymptomatic average-risk persons
55. A normal initial colonoscopy after age 50 does not predict a polyp-free status for life
56. Randomized trial of the addition of flexible sigmoidoscopy to faecal occult blood testing for colorectal neoplasia population screening
57. Population based randomized study of uptake and yield of screening by flexible sigmoidoscopy compared with screening by faecal occult blood testing
58. Adding new fecal occult blood tests to sigmoidoscopy: What is the added yield?
59. Relative sensitivity of colonoscopy and barium enema for detection of colorectal cancer in clinical practice
60. Colorectal cancer overlooked at barium enema examination and colonoscopy: A continuing perceptual problem. A retrospective 5-year study on the accuracy of the barium enema examination performed by radiographers
61. Utility of flexible sigmoidoscopy as an adjunct to double-contrast barium enema examination
62. Colon cancer at barium enema examination and colonoscopy: A study from the county of Hordaland, Norway
63. A retrospective 5-year study on the accuracy of the barium enema examination performed by radiographers
64. Barium enema: Detection of colonic lesions in a community population
65. Accuracy of double contrast barium enema and sigmoideoscopy in the detection of polyps in patients with diverticulosis
66. Metachronous colon cancer in persons who have had a large adenomatous polyp
67. A comparison of colonoscopy and double-contrast barium enema for surveillance after polypectomy
68. A comparison of virtual and conventional colonoscopy for the detection of colorectal polyps
69. An initial experience with screening for colon polyps using spiral CT with and without CT colography (virtual colonoscopy)
70. Detection of colorectal polyps with CT colography: Initial assessment of sensitivity and specificity
71. CT colonography with three-dimensional problem solving for detection of colonic polyps
72. Is virtual colonoscopy a cost-effective option to screen for colorectal cancer?
73. Identification of ras oncogene mutations in the stool of patients with curable colorectal tumors
74. Mutant K-ras in apparently normal mucosa of colorectal cancer patients. Its potential as a biomarker of colorectal tumorigenesis
75. Detection of K-ras mutation in colonic effluent samples from patients without evidence of colorectal carcinoma
76. Detection of altered DNA in the stool: Feasibility for colorectal neoplasia screening
77. Colorectalert: A novel test for colorectal cancer screening
78. Results of screening, rescreening, and follow-up in a prospective randomized study for detection of colorectal cancer by fecal occult blood testing. Results for 68,308 subjects
79. Is colonoscopy indicated for small adenomas found by screening flexible sigmoidoscopy?
80. Do characteristics of adenomas on flexible sigmoidoscopy predict advanced lesions on baseline colonoscopy?
81. Risk of advanced proximal neoplasms in asymptomatic adults according to the distal colorectal findings